CoAssist Pharmacy LLC
In good standing at check · Oklahoma (non-resident pharmacy)
License 99-9069 · recorded expiry
2400 Sand Lake Road, Suite 200, Orlando, FL 32809
State registry record ↗ (opens in a new tab)Checked
Company profile
Ro offers online weight-management care through its Body membership. The service separates membership and medication charges and describes access to healthcare providers; prescribing and medication eligibility depend on an individual assessment.
ro.co (opens in a new tab)Source-based assessment
Public pricing and terms distinguish membership from medication. The NovoCare channel was traced to CoAssist and a current Oklahoma license; other channels and individual clinician credentials remain unverified.
Benchmark score
47% of criteria assessed · Checked
A source changed. The last approved score remains visible while the update is reviewed.
Limited evidence
This score covers the assessed criteria only. Read it alongside the evidence coverage, unverified findings and any documented concerns below. A high score with limited coverage does not establish a complete assessment or a verified pharmacy license.
The same criteria measure verifiable operating disclosures and registry evidence. They do not establish medical safety, product purity or clinical outcomes.
Ro publishes membership pricing and terms identifying its operator and customer contact channels.
Named operator, an attributed physical business address and a working-purpose contact telephone. Distinguish registered or correspondence offices from clinical and dispensing locations; online care does not require a walk-in clinic. Weight: 8%.
The service describes access to providers, but no individual clinician license was matched.
Who the service is for, prescribing or research-use boundaries, and provider information. Weight: 5%.
The pricing page separates membership from medication and distinguishes prepaid membership options.
Public prices or a defined quotation process, with recurring or additional charges explained. Weight: 5%.
Published terms identify the operator and govern recurring purchases and cancellation.
Accessible cancellation, refund or ordering terms and a support channel. Weight: 4%.
Ro names NovoCare Pharmacy in an integration announcement; this does not establish every prescription destination.
Named dispensing partners for care services; analytical documentation or manufacturing information for research businesses. Weight: 10%.
An entity-specific regulatory assessment has not been completed. No clean record or adverse finding is inferred.
Entity/product-specific regulatory notices, enforcement, recalls and their resolution, with dates and jurisdiction. A pharmacy license match alone is not a regulatory-history review. No clean record is inferred from silence. Weight: 10%.
This criterion has not yet been established from the reviewed evidence.
Product- and lot-specific laboratory reports covering molecule identity and purity, with the laboratory, report date and issuer authenticity check. Full credit requires independently established laboratory identity and a traceable verified report. A testing policy or a report for another batch provides limited evidence only; purity does not establish sterility, endotoxin control or treatment safety. Weight: 12%.
This criterion has not yet been established from the reviewed evidence.
An applicable external accreditation, such as LegitScript for healthcare, matched to the exact business or domain in the issuer’s records. A badge alone does not establish current certification. Weight: 3%.
This criterion has not yet been established from the reviewed evidence.
Accessible privacy terms identifying the responsible entities, data uses and applicable health-data notice. A HIPAA claim is not independent verification of compliance; HIPAA is not required of every research business. Weight: 6%.
This criterion has not yet been established from the reviewed evidence.
Specific, dated evidence of relevant security practices or an independently issued audit, with its entity, scope and limits. HTTPS, a marketing seal or a claim of being unhackable is insufficient. Weight: 6%.
This criterion has not yet been established from the reviewed evidence.
Disclosed payment processing, billing authorization and recurring-charge arrangements. No processor brand is preferred and a processor does not certify the provider’s clinical or product quality. Weight: 3%.
This criterion has not yet been established from the reviewed evidence.
Clear product identity and intended use, distinguishing branded medicines, compounded preparations and research materials; presentation and preparation requirements where relevant. A compounded product is not assumed to be an approved generic. Weight: 8%.
This criterion has not yet been established from the reviewed evidence.
Product-specific delivery, temperature and storage instructions, including handling of shipping problems. Refrigeration, freezing or a particular presentation receives no automatic quality bonus. Weight: 5%.
Ro discloses a NovoCare integration. NovoCare and AssistRx identify CoAssist as its dispensing operator. Oklahoma lists CoAssist license 99-9069 in good standing. This is one channel and one state, not confirmation of every Ro prescription destination.
At least one exactly named dispensing partner matched to an active, unreplaced official state record. This does not verify all partners or all jurisdictions. Weight: 15%.
An active state record was matched for a named pharmacy.
Company-disclosed names: NovoCare Pharmacy, CoAssist Pharmacy LLC
Ro discloses a NovoCare integration. NovoCare and AssistRx identify CoAssist as its dispensing operator. Oklahoma lists CoAssist license 99-9069 in good standing. This is one channel and one state, not confirmation of every Ro prescription destination.
In good standing at check · Oklahoma (non-resident pharmacy)
License 99-9069 · recorded expiry
2400 Sand Lake Road, Suite 200, Orlando, FL 32809
State registry record ↗ (opens in a new tab)Checked
Each record covers only the named pharmacy and jurisdiction. It does not establish nationwide authorization, clinical quality, every partner’s status or who will dispense an individual prescription. Individual clinician licenses have not been matched.
A closer look
A laboratory report describes a particular sample. Check the product, lot, date and tests before applying it to another medication or shipment.
A product-specific report has not been established from the reviewed public evidence.
Identity, purity, potency, sterility and endotoxins are separate tests. A report does not establish clinical suitability or certify every batch supplied by a provider.
Go a little deeper
Explore a detailed report of Ro’s evidence, costs and open questions.
Community experiences
No customer reviews yet. These opinions are separate from the editorial benchmark and do not change its score.
Email verification confirms account access, not a purchase or the accuracy of an opinion. Review guidelines